Примери за използване на Flushing solution на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Withdraw flushing solution.
Preparation for administration of Brineura and flushing solution.
Administer flushing solution after Brineura.
Remove the yellow flip-off cap from the flushing solution vial.
The flushing solution contains the inactive ingredients only.
Inspect thawed Brineura and flushing solution vials.
Brineura and flushing solution are supplied and stored frozen(see section 6.4).
Administer the flushing solution provided after the Brineura infusion is complete.
This medicinal product contains 44 mg sodium per vial of Brineura and flushing solution.
Thawed Brineura and flushing solution should be used immediately.
Do not re-freeze vials orfreeze syringes containing Brineura or flushing solution.
Initiate infusion of the flushing solution at a rate of 2.5 ml per hour.
The flushing solution may contain particles that dissolve when the vial is fully thawed.
Brineura has a green flip-off cap and flushing solution has a yellow flip-off cap.
Brineura and flushing solution vials should be thawed prior to administration.
Attach the syringe containing the calculated volume of flushing solution to the infusion components(see section 6.6).
Brineura and the flushing solution must only be administered by the intracerebroventricular route.
Pack size: 3 vials(two vials of Brineura and one vial of flushing solution), each containing 5 ml of solution. .
Brineura and flushing solution should be clear to slightly opalescent and colourless to pale yellow.
For instructions on preparation of Brineura and flushing solution before administration, see section 6.6.
Brineura and flushing solution must be completely thawed and used immediately(see section 6.3).
The following components(not supplied) are required for proper administration of Brineura and flushing solution(see Figure 1 in section 4.2).
Each vial of Brineura and flushing solution are intended for single use only.
Brineura should be administered with infusion components shown to be chemically andphysically compatible with administration of Brineura and flushing solution.
Thaw Brineura vials and flushing solution vial at room temperature for approximately 60 minutes.
Pack size of three vials: two 10 ml vials, each containing 150 mg of cerliponase alfa in 5 ml of solution; and one 10 ml vial,containing 5 ml flushing solution.
Determine the volume of flushing solution needed to ensure complete delivery of Brineura to the cerebral ventricles.
The complete infusion time,including Brineura and the required flushing solution, is approximately 2 to 4.5 hours, depending on the dose and volume administered.
The other ingredients of Brineura and the flushing solution are: sodium phosphate dibasic heptahydrate, sodium dihydrogen phosphate monohydrate, sodium chloride, potassium chloride, magnesium chloride hexahydrate, calcium chloride dihydrate, and water for injections(see section 2“Brineura contains sodium”).